Ex vivo cytokine production by whole mid-trimester amniotic fluid

Journal of Reproductive Immunology

Volumn 78, Issue 1, 2008, Pages 22-27

  Sezen, Devrim ^a   Bongiovanni, Ann Marie ^a   Jean Pierre, Claudel ^a   Linhares, Iara Moreno ^a,b   Skupski, Daniel ^a,b   Witkin, Steven S ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NEW YORK HOSPITAL QUEENS   (United States)

Author keywords

Ex vivo cytokine production; Mid trimester amniotic fluid; Pro inflammatory cytokines; Spontaneous preterm birth

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NITRIC OXIDE;

AMNION FLUID; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; EX VIVO STUDY; FEMALE; HUMAN; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; TERM BIRTH;

ADULT; AMNIOTIC FLUID; CYTOKINES; FEMALE; HUMANS; LIPOPOLYSACCHARIDES; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PREMATURE BIRTH;

EID: 42949085706     PISSN: 01650378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jri.2007.08.001     Document Type: Article

References (27)

1. Baggia S., Gravett M.G., Witkin S.S., Haluska G.J., and Novy M.J. Interleukin-1β intraamniotic infusion induces tumor necrosis factor-α, prostaglandin production, and preterm contractions in pregnant rhesus monkeys. J. Soc. Gynecol. Invest. 3 (1996) 121-126
2. Bogdan C., Rollinghoff M., and Diefenbach A. Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. Curr. Opin. Immunol. 12 (2000) 64-76
3. Chan T.F., Chung Y.F., Chen H.S., Su J.H., and Yuan S.S. Elevated amniotic fluid leptin levels in early second trimester are associated with earlier delivery and lower birthweight in twin pregnancy. Acta Obstet. Gynecol. Scand. 83 (2004) 707-710
4. Gerber S., Vial Y., Hohlfeld P., and Witkin S.S. Detection of Ureaplasma urealyticum in second-trimester amniotic fluid by polymerase chain reaction correlates with subsequent preterm labor and delivery. J. Infect. Dis. 187 (2003) 518-521
5. Ghezzi F., Franchi M., Raio L., Di Naro E., Bossi G., Melzi D'Eril G.V., et al. Elevated amniotic fluid C-reactive protein at the time of genetic amniocentesis is a marker for preterm delivery. Am. J. Obstet. Gynecol. 186 (2002) 273-288
6. Gomez R., Romero R., Ghezzi F., Yoon B.H., Mazor M., and Berry S.M. The fetal inflammatory response syndrome. Am. J. Obstet. Gynecol. 179 (1998) 194-202
7. Heyborne K.D., McGregor J.A., Henry G., Witkin S.S., and Abrams J.S. Interleukin-10 in amniotic fluid at midtrimester: immune activation and suppression in relation to fetal growth. Am. J. Obstet. Gynecol. 171 (1994) 55-59
8. Hillier S.L., Witkin S.S., Krohn M.A., Watts D.H., Kiviat N.B., and Eschenbach D.A. The relationship of amniotic fluid cytokines and preterm delivery, amniotic fluid infection, histologic chorioamnionitis, and chorioamnion infection. Obstet. Gynecol. 81 (1993) 941-948
9. Hoehn H., and Salk D. Morphological and biochemical heterogeneity of amniotic fluid cells in culture. Methods Cell Biol. 26 (1982) 11-34
10. Hsu C.D., Meaddough E., Lu L.C., Chelouche A., Liang R.I., Copel J.A., et al. Immunohistochemical localization of inducible nitric oxide synthase on human fetal amnion in intra-amniotic infection. Am. J. Obstet. Gynecol. 179 (1998) 1271-1274
11. Jean-Pierre C., Perni S.C., Bongiovanni A.M., Kalish R.B., Karasahan E., Ravich M., et al. Extracellular 70-kD heat shock protein in mid-trimester amniotic fluid and its effect on cytokine production by ex vivo-cultured amniotic fluid cells. Am. J. Obstet. Gynecol. 194 (2006) 694-698
12. Jones S.A. Directing transition from innate to acquired immunity: defining a role for IL-6. J. Immunol. 175 (2005) 3463-3468
13. Madazli R., Atis A., Uzun H., and Aksu F. Mid-trimester amniotic fluid angiogenin, lactate dehydrogenase and fibronectin in the prediction of preterm delivery. Eur. J. Obstet. Gynecol. Reprod. Biol. 106 (2003) 160-164
14. Ojeda M.J., Silva C.V., Rosainz M.J., and Fernandez-Ortega C. TNFα production in whole blood cultures from healthy individuals. Biochem. Biophys. Res. Commun. 292 (2002) 538-541
15. Opal S.M., Wherry J.C., and Grint P. Interleukin-10: potential benefits and possible risks in clinical infectious diseases. Clin. Infect. Dis. 27 (1998) 1497-1507
16. Perni S.C., Vardhana S., Korneeva I., Tuttle S.L., Paraskevas L.R., Chasen S.T., et al. Mycoplasma hominis and Ureaplasma urealyticum in midtrimester amniotic fluid: association with amniotic fluid cytokine levels and pregnancy outcome. Am. J. Obstet. Gynecol. 191 (2004) 1382-1386
17. Prusa A.R., and Hengstschlager M. Amniotic fluid cells and human stem cell research-a new connection. Med. Sci. Monit. 8 (2002) 253-257
18. Romero R., Avila C., Santhanam U., and Sehgal P.B. Amniotic fluid interleukin 6 in preterm labor. Association with Infection. J. Clin. Invest. 85 (1990) 1392-1400
19. Sadowsky D.W., Adams K.M., Gravett M.G., Witkin S.S., and Novy M.J. Preterm labor is induced by intraamniotic infusions of interleukin-1β and tumor necrosis factor-α but not by interleukin-6 or interleukin-8 in a nonhuman primate model. Am. J. Obstet. Gynecol. 195 (2006) 1578-1589
20. Sadowsky D.W., Novy M.J., Witkin S.S., and Gravett M.G. Dexamethasone or interleukin-10 blocks interleukin-1β-induced uterine contractions in pregnant rhesus monkeys. Am. J. Obstet. Gynecol. 188 (2003) 252-263
21. von Mandach U., Lauth D., and Huch R. Maternal and fetal nitric oxide production in normal and abnormal pregnancy. J. Mat. Fetal Neonatal Med. 13 (2003) 22-27
22. Vrachnis N., Malamitsi-Puchner A., Samoli E., Botsis D., Iliodromiti Z., Baka S., et al. Elevated mid-trimester amniotic fluid ADAM-8 concentrations as a potential risk factor for preterm delivery. J. Soc. Gynecol. Invest. 13 (2006) 186-190
23. Wenstrom K.D., Andrews W.W., Hauth J.C., Goldenberg R.L., DuBard M.B., and Cliver S.P. Elevated second-trimester amniotic fluid interleukin-6 levels predict preterm delivery. Am. J. Obstet. Gynecol. 178 (1998) 546-550
24. White C.A., Johansson M., Roberts C.T., Ramsay A.J., and Robertson S.A. Effect of interleukin-10 null mutation on maternal immune response and reproductive outcome in mice. Biol. Reprod. 70 (2004) 123-131
25. Witkin S.S., Gravett M.G., Haluska G.J., and Novy M.J. Induction of interleukin-1 receptor antagonist in rhesus monkeys after intraamniotic infection with group B streptococci or interleukin-1 infusion. Am. J. Obstet. Gynecol. 171 (1994) 1688-1692
26. Witkin S.S., Vardhana S., Yih M., Doh K., Bongiovanni A.M., and Gerber S. Polymorphism in intron 2 of the fetal interleukin-1 receptor antagonist genotype influences midtrimester amniotic fluid concentrations of interleukin-1β and interleukin-1 receptor antagonist and pregnancy outcome. Am. J. Obstet. Gynecol. 189 (2003) 1413-1417
27. Yoon B.H., Oh S.Y., Romero R., Shim S.S., Han S.Y., Park J., et al. An elevated amniotic fluid metalloproteinase-8 level at the time of mid-trimester genetic amniocentesis is a risk factor for spontaneous preterm delivery. Am. J. Obstet. Gynecol. 185 (2001) 1162-1167